Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;21(1):110.
doi: 10.1186/s12874-021-01293-y.

Randomized test-treatment studies with an outlook on adaptive designs

Affiliations
Free PMC article

Randomized test-treatment studies with an outlook on adaptive designs

Amra Hot et al. BMC Med Res Methodol. .
Free PMC article

Abstract

Background: Diagnostic accuracy studies aim to examine the diagnostic accuracy of a new experimental test, but do not address the actual merit of the resulting diagnostic information to a patient in clinical practice. In order to assess the impact of diagnostic information on subsequent treatment strategies regarding patient-relevant outcomes, randomized test-treatment studies were introduced. Various designs for randomized test-treatment studies, including an evaluation of biomarkers as part of randomized biomarker-guided treatment studies, are suggested in the literature, but the nomenclature is not consistent.

Methods: The aim was to provide a clear description of the different study designs within a pre-specified framework, considering their underlying assumptions, advantages as well as limitations and derivation of effect sizes required for sample size calculations. Furthermore, an outlook on adaptive designs within randomized test-treatment studies is given.

Results: The need to integrate adaptive design procedures in randomized test-treatment studies is apparent. The derivation of effect sizes induces that sample size calculation will always be based on rather vague assumptions resulting in over- or underpowered study results. Therefore, it might be advantageous to conduct a sample size re-estimation based on a nuisance parameter during the ongoing trial.

Conclusions: Due to their increased complexity, compared to common treatment trials, the implementation of randomized test-treatment studies poses practical challenges including a huge uncertainty regarding study parameters like the expected outcome in specific subgroups or disease prevalence which might affect the sample size calculation. Since research on adaptive designs within randomized test-treatment studies is limited so far, further research is recommended.

Keywords: Accuracy; Adaptive design; Diagnostic research; Patient-relevant outcome; RCT; Sample size; Test-treatment.

PubMed Disclaimer

References

    1. Stat Med. 2020 Feb 28;39(5):591-601 - PubMed
    1. Clin Pharmacol Ther. 2001 Mar;69(3):89-95 - PubMed
    1. Stat Methods Med Res. 2018 Nov;27(11):3286-3303 - PubMed
    1. Med Decis Making. 2009 Sep-Oct;29(5):E13-21 - PubMed
    1. Ann Intern Med. 2006 Jun 6;144(11):850-5 - PubMed

Publication types

LinkOut - more resources